Bacterial adhesion to bisphosphonate coated hydroxyapatite.

Area of Science:

• Biomaterials Science
• Orthopaedic Surgery
• Infectious Diseases

Background:

• Staphylococcus aureus (S. aureus) infections are a major cause of orthopaedic implant failure, leading to osteomyelitis and bone destruction.
• Hydroxyapatite (HA) ceramic is used in artificial hip joints, and osteolysis (bone loss) can cause implant loosening.
• Coating HA with bisphosphonates like clodronate (C) and pamidronate (P) is explored to minimize osteolysis.

Purpose of the Study:

• To evaluate the effect of bisphosphonate coatings (clodronate and pamidronate) on bacterial adhesion of S. aureus to hydroxyapatite (HA) materials.
• To determine if bisphosphonate coating influences the risk of implant-associated infection.

Main Methods:

• Hydroxyapatite (HA) materials were coated with clodronate (C) and pamidronate (P).
• Coated and uncoated HA materials were incubated with Staphylococcus aureus (S. aureus).
• Bacterial adhesion was quantified using the Modified Vortex Device (MVD) method.

Main Results:

• Pamidronate (P)-coated HA showed a significantly greater number of adherent S. aureus compared to uncoated HA (60-fold increase).
• P-coated HA also exhibited a higher bacterial adhesion than C-coated HA (90-fold increase).
• Clodronate (C)-coated HA did not show a significant increase in bacterial adhesion compared to uncoated HA.

Conclusions:

• While pamidronate (P) may enhance osseointegration, its coating on HA materials significantly increases S. aureus adhesion.
• The increased bacterial adhesion suggests a potential limitation for P-coated HA implants due to a higher risk of infection.
• Further research is needed to balance the benefits of bisphosphonate coatings with the risk of implant-associated infections.